Details of Protein
| General Information of Protein (ID: PRT00675) | |||||
|---|---|---|---|---|---|
| Name | Lysophosphatidic acid receptor 5 (LPAR5) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
LPA receptor 5; LPA-5; G-protein coupled receptor 92; G-protein coupled receptor 93; LPAR5; GPR92; GPR93
|
||||
| Gene Name | LPAR5 | Gene ID | |||
| UniProt ID | |||||
| Family | GPCR rhodopsin (GPCR-1) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MLANSSSTNSSVLPCPDYRPTHRLHLVVYSLVLAAGLPLNALALWVFLRALRVHSVVSVY
MCNLAASDLLFTLSLPVRLSYYALHHWPFPDLLCQTTGAIFQMNMYGSCIFLMLINVDRY AAIVHPLRLRHLRRPRVARLLCLGVWALILVFAVPAARVHRPSRCRYRDLEVRLCFESFS DELWKGRLLPLVLLAEALGFLLPLAAVVYSSGRVFWTLARPDATQSQRRRKTVRLLLANL VIFLLCFVPYNSTLAVYGLLRSKLVAASVPARDRVRGVLMVMVLLAGANCVLDPLVYYFS AEGFRNTLRGLGTPHRARTSATNGTRAALAQSERSAVTTDATRPDAASQGLLRPSDSHSL SSFTQCPQDSAL |
||||
| Function | Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulating This Protein | ||||||
|---|---|---|---|---|---|---|
| Lipids and lipid-like molecules | ||||||
| Farnesyl pyrophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Farnesyl pyrophosphate addition (24 hours) | |||||
| Induced Change | LPAR5 protein activity levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
| Details | It is reported that farnesyl pyrophosphate addition causes the increase of LPAR5 protein activity compared with control group. | |||||
| Organic acids and derivatives | ||||||
| N-Arachidonoylglycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | N-Arachidonoylglycine addition (24 hours) | |||||
| Induced Change | LPAR5 protein activity levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
| Details | It is reported that N-arachidonoylglycine addition causes the increase of LPAR5 protein activity compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem. 2009 Jun 19;284(25):17304-17319. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

